NCT05451784: Treatment of Advanced or Metastatic Triple-negative Breast Cancer With Adoptive Therapy of PD1+ TILS
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 20 planned
- Started
- 20 Jul 2022
- Primary completion
- 30 Sep 2028
- Arms
- PD1+ TILs (NUMARZU-001) product infusion
- Results
- None posted
- 11 Jul 2022: Trial registered
- 20 Jul 2022: Trial started